← Eichor
Condition: Cin 2 3 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cin 2 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Phase 4 · 1 location(s) · Miriam Elfström · NCT04910802
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353
Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05027776
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Phase 2 · 7 location(s) · Frantz Viral Therapeutics, LLC · NCT04098744
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.